DaVita Inc. (NYSE:DVA) Shares Bought by Worldquant Millennium Advisors LLC

Worldquant Millennium Advisors LLC lifted its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 154.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 95,372 shares of the company's stock after acquiring an additional 57,883 shares during the period. Worldquant Millennium Advisors LLC owned 0.12% of DaVita worth $14,263,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. United Capital Financial Advisors LLC increased its position in DaVita by 2.6% during the 4th quarter. United Capital Financial Advisors LLC now owns 2,416 shares of the company's stock worth $361,000 after purchasing an additional 62 shares in the last quarter. Freedom Investment Management Inc. increased its position in DaVita by 3.6% during the 4th quarter. Freedom Investment Management Inc. now owns 1,790 shares of the company's stock worth $268,000 after purchasing an additional 62 shares in the last quarter. Exchange Traded Concepts LLC increased its position in DaVita by 8.3% during the 4th quarter. Exchange Traded Concepts LLC now owns 891 shares of the company's stock worth $133,000 after purchasing an additional 68 shares in the last quarter. Impact Partnership Wealth LLC increased its position in DaVita by 3.7% during the 4th quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company's stock worth $290,000 after purchasing an additional 70 shares in the last quarter. Finally, Nilsine Partners LLC increased its position in DaVita by 0.8% during the 4th quarter. Nilsine Partners LLC now owns 11,160 shares of the company's stock worth $1,669,000 after purchasing an additional 92 shares in the last quarter. 90.12% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

DVA has been the subject of a number of research analyst reports. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a research report on Friday, April 25th. Truist Financial dropped their target price on shares of DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a research report on Monday, May 19th. Barclays increased their target price on shares of DaVita from $164.00 to $169.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 18th. Cowen reaffirmed a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research note on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, DaVita presently has a consensus rating of "Hold" and a consensus price target of $164.50.

DaVita Stock Up 0.8%

DVA traded up $1.14 during trading hours on Tuesday, reaching $139.33. 107,832 shares of the stock traded hands, compared to its average volume of 872,424. The firm's fifty day simple moving average is $145.09 and its two-hundred day simple moving average is $153.34. The company has a market cap of $10.52 billion, a price-to-earnings ratio of 12.95, a PEG ratio of 1.07 and a beta of 1.14. DaVita Inc. has a fifty-two week low of $131.76 and a fifty-two week high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, beating analysts' consensus estimates of $1.75 by $0.25. The business had revenue of $3.22 billion during the quarter, compared to analyst estimates of $3.22 billion. DaVita had a net margin of 7.31% and a return on equity of 115.48%. The business's revenue was up 5.0% on a year-over-year basis. During the same period last year, the business earned $2.26 EPS. As a group, analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.